These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26034396)

  • 21. Melatonin receptor agonists-ramelteon and melatonin-for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.
    Kishi T; Nomura I; Sakuma K; Kitajima T; Mishima K; Iwata N
    Neuropsychiatr Dis Treat; 2019; 15():1479-1486. PubMed ID: 31239683
    [No Abstract]   [Full Text] [Related]  

  • 22. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Travel Med Infect Dis; 2008; 6(1-2):17-28. PubMed ID: 18342269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin or ramelteon therapy differentially affects hepatic gene expression profiles after haemorrhagic shock in rat--A microarray analysis.
    Kleber A; Ruf CG; Wolf A; Fink T; Glas M; Wolf B; Volk T; Abend M; Mathes AM
    Exp Mol Pathol; 2015 Oct; 99(2):189-97. PubMed ID: 26116814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use.
    Baltatu OC; Senar S; Campos LA; Cipolla-Neto J
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
    Nishiyama K; Shintani Y; Hirai K; Yoshikubo S
    J Pharmacol Exp Ther; 2009 Sep; 330(3):855-63. PubMed ID: 19556449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ramelteon: new drug. Insomnia: no role for risky placebos.
    Prescrire Int; 2008 Oct; 17(97):183-6. PubMed ID: 19534018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigational melatonin receptor agonists.
    Hardeland R
    Expert Opin Investig Drugs; 2010 Jun; 19(6):747-64. PubMed ID: 20408738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels.
    Stroethoff M; Christoph I; Behmenburg F; Raupach A; Bunte S; Senpolat S; Heinen A; Hollmann MW; Mathes A; Huhn R
    J Cardiovasc Pharmacol; 2018 Aug; 72(2):106-111. PubMed ID: 29787401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of Melatonin Receptors by Ramelteon Induces Cardioprotection by Postconditioning in the Rat Heart.
    Stroethoff M; Behmenburg F; Spittler K; Raupach A; Heinen A; Hollmann MW; Huhn R; Mathes A
    Anesth Analg; 2018 Jun; 126(6):2112-2115. PubMed ID: 29381514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ramelteon for the treatment of insomnia.
    Borja NL; Daniel KL
    Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune hepatitis in association with ramelteon.
    Fourman LT; Robert Meyer B
    J Clin Gastroenterol; 2013 Aug; 47(7):651-4. PubMed ID: 23632362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in melatonin receptor ligands.
    Zlotos DP
    Arch Pharm (Weinheim); 2005 Jun; 338(5-6):229-47. PubMed ID: 15952241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Ramelteon and Other Sleep-Promoting Drugs on Serum Low-Density Lipoprotein and Non-high-density Lipoprotein Cholesterol: A Retrospective Comparative Pilot Study.
    Torii H; Shimizu R; Tanizaki Y; Omiya Y; Yamamoto M; Kamiike S; Yasuda D; Hiraoka Y; Hashida T; Kume N
    Biol Pharm Bull; 2018; 41(12):1778-1790. PubMed ID: 30504680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of M-II, the major human metabolite of ramelteon.
    Nishiyama K; Nishikawa H; Kato K; Miyamoto M; Tsukamoto T; Hirai K
    Pharmacology; 2014; 93(3-4):197-201. PubMed ID: 24923230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response.
    Zhou W; Zhang X; Zhu CL; He ZY; Liang JP; Song ZC
    PLoS One; 2016; 11(11):e0166442. PubMed ID: 27832188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging Role of Melatonin and Melatonin Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients.
    Mo Y; Scheer CE; Abdallah GT
    J Intensive Care Med; 2016 Aug; 31(7):451-5. PubMed ID: 26092575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin receptor agonists for treating delirium in elderly patients with acute stroke.
    Ohta T; Murao K; Miyake K; Takemoto K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1107-10. PubMed ID: 23017429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat.
    Mathes AM; Kubulus D; Waibel L; Weiler J; Heymann P; Wolf B; Rensing H
    Crit Care Med; 2008 Oct; 36(10):2863-70. PubMed ID: 18766086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer.
    Moreno-SanJuan S; Puentes-Pardo JD; Casado J; Escudero-Feliu J; Khaldy H; Arnedo J; Carazo Á; León J
    Antioxidants (Basel); 2023 Apr; 12(4):. PubMed ID: 37107301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy.
    Petronek MS; Stolwijk JM; Murray SD; Steinbach EJ; Zakharia Y; Buettner GR; Spitz DR; Allen BG
    Redox Biol; 2021 Jun; 42():101864. PubMed ID: 33485837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.